Aim & Planned activities

The overall objective of the SHIGETECVAX project is to advance the ShigETEC vaccine candidate into early clinical development, with the ultimate goal of developing an effective vaccine suitable for different populations, in particular for use in paediatric population in low- and middle-income countries. 


In order to achieve this goal, the following activities are planned:

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

  • LinkedIn - White Circle
  • Twitter - White Circle

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 815568

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative